Trastuzumab
Trastuzumab is a humanized monoclonal antibody for patients with invasive breast cancers that overexpress HER2. Trastuzumab has been clinically used to treat HER2 Positive Metastatic Breast Cancer and HER2 Positive Gastric Cancer.
Product Specifications
CAS Number
180288-69-1
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
146 kDa
Molecular Formula
——
Notes
Research use only, not for human use.
Receptor
HER2
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1077431-01 0.05 mg (E-Coli)
Recombinant Marinobacter aquaeolei Peptide chain release factor 1 (prfA)
Ask
View Details 
MBS1077431-02 0.05 mg (Yeast)
Recombinant Marinobacter aquaeolei Peptide chain release factor 1 (prfA)
Ask
View Details MBS1077431-03 0.05 mg (Baculovirus)
Recombinant Marinobacter aquaeolei Peptide chain release factor 1 (prfA)
Ask
View Details MBS1077431-04 0.2 mg (E-Coli)
Recombinant Marinobacter aquaeolei Peptide chain release factor 1 (prfA)
Ask
View Details 
MBS1077431-05 0.5 mg (E-Coli)
Recombinant Marinobacter aquaeolei Peptide chain release factor 1 (prfA)
Ask
View Details